These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 20232057

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice.
    Bagdas D, Muldoon PP, Zhu AZ, Tyndale RF, Damaj MI.
    Neuropharmacology; 2014 Oct; 85():67-72. PubMed ID: 24859605
    [Abstract] [Full Text] [Related]

  • 44. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.
    Castañé A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O.
    Neuropharmacology; 2002 Oct; 43(5):857-67. PubMed ID: 12384171
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Effects of Chronic Social Defeat Stress on Sleep and Circadian Rhythms Are Mitigated by Kappa-Opioid Receptor Antagonism.
    Wells AM, Ridener E, Bourbonais CA, Kim W, Pantazopoulos H, Carroll FI, Kim KS, Cohen BM, Carlezon WA.
    J Neurosci; 2017 Aug 09; 37(32):7656-7668. PubMed ID: 28674176
    [Abstract] [Full Text] [Related]

  • 47. Buprenorphine reduces somatic withdrawal in a mouse model of early-life morphine exposure.
    Lepore G, Morley-McLaughlin T, Davidson N, Han C, Masese C, Reynolds G, Saltz V, Robinson SA.
    Drug Alcohol Depend; 2023 Jul 01; 248():109938. PubMed ID: 37267743
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
    Cryan JF, Bruijnzeel AW, Skjei KL, Markou A.
    Psychopharmacology (Berl); 2003 Jul 01; 168(3):347-58. PubMed ID: 12698231
    [Abstract] [Full Text] [Related]

  • 51. Antinociceptive effects of alcohol and nicotine: involvement of the opioid system.
    Campbell VC, Taylor RE, Tizabi Y.
    Brain Res; 2006 Jun 30; 1097(1):71-7. PubMed ID: 16730342
    [Abstract] [Full Text] [Related]

  • 52. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A, Khani A, Naderi N, Alizadeh AM, Motamedi F.
    Pharmacol Biochem Behav; 2008 Feb 30; 88(4):385-92. PubMed ID: 17915302
    [Abstract] [Full Text] [Related]

  • 53. Endogenous opioid system: a promising target for future smoking cessation medications.
    Norman H, D'Souza MS.
    Psychopharmacology (Berl); 2017 May 30; 234(9-10):1371-1394. PubMed ID: 28285326
    [Abstract] [Full Text] [Related]

  • 54. Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.
    Pipkin JA, Cruz B, Flores RJ, Hinojosa CA, Carcoba LM, Ibarra M, Francis W, Nazarian A, O'Dell LE.
    Psychopharmacology (Berl); 2017 May 30; 234(9-10):1615-1622. PubMed ID: 28342091
    [Abstract] [Full Text] [Related]

  • 55. Antinociceptive effect of chronic nicotine and nociceptive effect of its withdrawal measured by hot-plate and tail-flick in rats.
    Yang CY, Wu WH, Zbuzek VK.
    Psychopharmacology (Berl); 1992 May 30; 106(3):417-20. PubMed ID: 1570390
    [Abstract] [Full Text] [Related]

  • 56. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H, Spaulding A, Leitermann R, Wu HE, Nagase H, Tseng LF.
    J Pharmacol Exp Ther; 2003 Jul 30; 306(1):394-400. PubMed ID: 12721333
    [Abstract] [Full Text] [Related]

  • 57. Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).
    Cai TB, Zou Z, Thomas JB, Brieaddy L, Navarro HA, Carroll FI.
    J Med Chem; 2008 Mar 27; 51(6):1849-60. PubMed ID: 18307295
    [Abstract] [Full Text] [Related]

  • 58. Design, synthesis, and biological evaluation of (3R)-1,2,3,4-tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide (JDTic) analogues: in vitro pharmacology and ADME profile.
    Kormos CM, Gichinga MG, Maitra R, Runyon SP, Thomas JB, Brieaddy LE, Mascarella SW, Navarro HA, Carroll FI.
    J Med Chem; 2014 Sep 11; 57(17):7367-81. PubMed ID: 25133923
    [Abstract] [Full Text] [Related]

  • 59. Age-dependent differences in nicotine reward and withdrawal in female mice.
    Kota D, Martin BR, Damaj MI.
    Psychopharmacology (Berl); 2008 Jun 11; 198(2):201-10. PubMed ID: 18338157
    [Abstract] [Full Text] [Related]

  • 60. Nicotine physical dependence and tolerance in the mouse following chronic oral administration.
    Grabus SD, Martin BR, Batman AM, Tyndale RF, Sellers E, Damaj MI.
    Psychopharmacology (Berl); 2005 Mar 11; 178(2-3):183-92. PubMed ID: 15365686
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.